| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8240708 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 7 Pages |
Abstract
Abnormal p53 is a significant prognostic factor for patients with prostate cancer who undergo short-term androgen deprivation and radiotherapy. Long-term androgen deprivation may significantly improve the cause-specific survival for those with abnormal p53.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Mingxin M.D., Ph.D., Michelle Ph.D., Alan M.D., Ph.D., David J. M.D., Varagur Mohan M.D., Gerald E. M.D., Howard M. M.D.,